Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,
Tag: Borrelia burgdorferi
Lyme disease has been strongly concentrated in the North American Midwest and Northeastern regions, where ticks and contact with ticks are common. According to